Clinical Trials Browser

Interventional × Respiratory Distress Syndrome × Clear all

Pulmonary Atelectasis, Bronchial Spasm, Disease, Lung Neoplasms, Pneumothorax, Postoperative Complications, Pulmonary Embolism, Respiratory Distress Syndrome, Respiratory Insufficiency

NCT04370834 2025-02-04

Tocilizumab for Patients With Cancer and COVID-19 Disease

Phase 2 Terminated

1 enrolled 10 charts

Other hematologic neoplasm

Pneumonia, Respiratory Distress Syndrome, Hematologic Neoplasms

NCT04466098 2025-01-29

Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)

Phase 2 Completed

8 enrolled 21 charts

Lymphoid

Cytokine Release Syndrome, COVID-19, Lymphoma, Follicular, Respiratory Distress Syndrome

NCT04394182 2022-03-29

ULTRA-COVID

Phase NA Suspended

15 enrolled

Cytokine Release Syndrome, Pneumonia, Viral, Respiratory Distress Syndrome

NCT02804945 2020-04-10

Mesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Patients With Malignancies

Phase 1 Completed

20 enrolled

Respiratory Distress Syndrome

NCT00141726 2015-12-03

Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant

Phase 2 Completed

34 enrolled 13 charts

Bronchiolitis Obliterans, Respiratory Distress Syndrome, Lung Injury, Acute Lung Injury

Clinical Trials

IPVB and POCs

Tocilizumab for Patients With Cancer and COVID-19 Disease

Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)

ULTRA-COVID

Mesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Patients With Malignancies

Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant